ID   CP2U1_HUMAN             Reviewed;         544 AA.
AC   Q7Z449; B2RMV7; Q96EQ6;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   10-MAY-2017, entry version 137.
DE   RecName: Full=Cytochrome P450 2U1;
DE            EC=1.14.14.1;
GN   Name=CYP2U1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Thymus;
RX   PubMed=14660610; DOI=10.1074/jbc.M311830200;
RA   Chuang S.S., Helvig C., Taimi M., Ramshaw H.A., Collop A.H., Amad M.,
RA   White J.A., Petkovich M., Jones G., Korczak B.;
RT   "CYP2U1, a novel human thymus- and brain-specific cytochrome P450,
RT   catalyzes omega- and (omega-1)-hydroxylation of fatty acids.";
RL   J. Biol. Chem. 279:6305-6314(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=14975754; DOI=10.1016/j.bbrc.2004.01.110;
RA   Karlgren M., Backlund M., Johansson I., Oscarson M.,
RA   Ingelman-Sundberg M.;
RT   "Characterization and tissue distribution of a novel human cytochrome
RT   P450-CYP2U1.";
RL   Biochem. Biophys. Res. Commun. 315:679-685(2004).
RN   [5]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15752708; DOI=10.1016/j.abb.2005.02.001;
RA   Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J.B.;
RT   "Expression patterns of mouse and human CYP orthologs (families 1-4)
RT   during development and in different adult tissues.";
RL   Arch. Biochem. Biophys. 436:50-61(2005).
RN   [6]
RP   VARIANTS SPG56 ARG-262; VAL-316; GLY-380 AND TRP-488.
RX   PubMed=23176821; DOI=10.1016/j.ajhg.2012.11.001;
RA   Tesson C., Nawara M., Salih M.A., Rossignol R., Zaki M.S.,
RA   Al Balwi M., Schule R., Mignot C., Obre E., Bouhouche A.,
RA   Santorelli F.M., Durand C.M., Oteyza A.C., El-Hachimi K.H.,
RA   Al Drees A., Bouslam N., Lamari F., Elmalik S.A., Kabiraj M.M.,
RA   Seidahmed M.Z., Esteves T., Gaussen M., Monin M.L., Gyapay G.,
RA   Lechner D., Gonzalez M., Depienne C., Mochel F., Lavie J., Schols L.,
RA   Lacombe D., Yahyaoui M., Al Abdulkareem I., Zuchner S., Yamashita A.,
RA   Benomar A., Goizet C., Durr A., Gleeson J.G., Darios F., Brice A.,
RA   Stevanin G.;
RT   "Alteration of fatty-acid-metabolizing enzymes affects mitochondrial
RT   form and function in hereditary spastic paraplegia.";
RL   Am. J. Hum. Genet. 91:1051-1064(2012).
CC   -!- FUNCTION: Catalyzes the hydroxylation of arachidonic acid,
CC       docosahexaenoic acid and other long chain fatty acids. May
CC       modulate the arachidonic acid signaling pathway and play a role in
CC       other fatty acid signaling processes.
CC       {ECO:0000269|PubMed:14660610}.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.7 uM for arachidonic acid;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:14660610}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:14660610}. Microsome membrane
CC       {ECO:0000269|PubMed:14660610}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7Z449-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z449-2; Sequence=VSP_026222, VSP_026223;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with stronger expression in
CC       thymus, heart and cerebellum. {ECO:0000269|PubMed:14660610,
CC       ECO:0000269|PubMed:14975754, ECO:0000269|PubMed:15752708}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal thymus.
CC       {ECO:0000269|PubMed:14660610, ECO:0000269|PubMed:15752708}.
CC   -!- DISEASE: Spastic paraplegia 56, autosomal recessive (SPG56)
CC       [MIM:615030]: A form of spastic paraplegia, a neurodegenerative
CC       disorder characterized by a slow, gradual, progressive weakness
CC       and spasticity of the lower limbs. Rate of progression and the
CC       severity of symptoms are quite variable. Initial symptoms may
CC       include difficulty with balance, weakness and stiffness in the
CC       legs, muscle spasms, and dragging the toes when walking.
CC       Complicated forms are recognized by additional variable features
CC       including spastic quadriparesis, seizures, dementia, amyotrophy,
CC       extrapyramidal disturbance, cerebral or cerebellar atrophy, optic
CC       atrophy, and peripheral neuropathy, as well as by extra
CC       neurological manifestations. In SPG56, upper limbs are often also
CC       affected. Some SPG56 patients may have a subclinical axonal
CC       neuropathy. {ECO:0000269|PubMed:23176821}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY343323; AAQ21380.1; -; mRNA.
DR   EMBL; CH471057; EAX06216.1; -; Genomic_DNA.
DR   EMBL; BC012027; AAH12027.1; -; mRNA.
DR   EMBL; BC132767; AAI32768.1; -; mRNA.
DR   EMBL; BC136483; AAI36484.1; -; mRNA.
DR   CCDS; CCDS34047.1; -. [Q7Z449-1]
DR   RefSeq; NP_898898.1; NM_183075.2. [Q7Z449-1]
DR   UniGene; Hs.109087; -.
DR   ProteinModelPortal; Q7Z449; -.
DR   SMR; Q7Z449; -.
DR   IntAct; Q7Z449; 1.
DR   STRING; 9606.ENSP00000333212; -.
DR   SwissLipids; SLP:000001048; -.
DR   iPTMnet; Q7Z449; -.
DR   PhosphoSitePlus; Q7Z449; -.
DR   BioMuta; CYP2U1; -.
DR   DMDM; 74762432; -.
DR   EPD; Q7Z449; -.
DR   MaxQB; Q7Z449; -.
DR   PaxDb; Q7Z449; -.
DR   PeptideAtlas; Q7Z449; -.
DR   PRIDE; Q7Z449; -.
DR   DNASU; 113612; -.
DR   Ensembl; ENST00000332884; ENSP00000333212; ENSG00000155016. [Q7Z449-1]
DR   GeneID; 113612; -.
DR   KEGG; hsa:113612; -.
DR   UCSC; uc003hyp.4; human. [Q7Z449-1]
DR   CTD; 113612; -.
DR   DisGeNET; 113612; -.
DR   GeneCards; CYP2U1; -.
DR   H-InvDB; HIX0024621; -.
DR   HGNC; HGNC:20582; CYP2U1.
DR   HPA; HPA041622; -.
DR   HPA; HPA046754; -.
DR   HPA; HPA064827; -.
DR   MalaCards; CYP2U1; -.
DR   MIM; 610670; gene.
DR   MIM; 615030; phenotype.
DR   neXtProt; NX_Q7Z449; -.
DR   OpenTargets; ENSG00000155016; -.
DR   Orphanet; 320411; Autosomal recessive spastic paraplegia type 56.
DR   PharmGKB; PA134924269; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118775; -.
DR   HOGENOM; HOG000036991; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; Q7Z449; -.
DR   KO; K07422; -.
DR   OMA; EDPFCPF; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; Q7Z449; -.
DR   TreeFam; TF352043; -.
DR   Reactome; R-HSA-211958; Miscellaneous substrates.
DR   Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
DR   SABIO-RK; Q7Z449; -.
DR   ChiTaRS; CYP2U1; human.
DR   GeneWiki; CYP2U1; -.
DR   GenomeRNAi; 113612; -.
DR   PRO; PR:Q7Z449; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000155016; -.
DR   CleanEx; HS_CYP2U1; -.
DR   ExpressionAtlas; Q7Z449; baseline and differential.
DR   Genevisible; Q7Z449; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:Reactome.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR008069; Cyt_P450_E_grp-I_CYP2D-like.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR01686; EP450ICYP2D.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Heme; Hereditary spastic paraplegia; Iron;
KW   Membrane; Metal-binding; Microsome; Monooxygenase; NADP;
KW   Neurodegeneration; Oxidoreductase; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    544       Cytochrome P450 2U1.
FT                                /FTId=PRO_0000291756.
FT   TRANSMEM     30     50       Helical. {ECO:0000255}.
FT   TRANSMEM    113    133       Helical. {ECO:0000255}.
FT   TRANSMEM    261    281       Helical. {ECO:0000255}.
FT   TRANSMEM    342    362       Helical. {ECO:0000255}.
FT   TRANSMEM    495    515       Helical. {ECO:0000255}.
FT   METAL       490    490       Iron (heme axial ligand). {ECO:0000250}.
FT   VAR_SEQ     164    168       GVVFA -> ELFQE (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026222.
FT   VAR_SEQ     169    544       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_026223.
FT   VARIANT     262    262       C -> R (in SPG56; dbSNP:rs397514515).
FT                                {ECO:0000269|PubMed:23176821}.
FT                                /FTId=VAR_069575.
FT   VARIANT     316    316       D -> V (in SPG56; dbSNP:rs397514513).
FT                                {ECO:0000269|PubMed:23176821}.
FT                                /FTId=VAR_069576.
FT   VARIANT     380    380       E -> G (in SPG56; dbSNP:rs397514514).
FT                                {ECO:0000269|PubMed:23176821}.
FT                                /FTId=VAR_069577.
FT   VARIANT     488    488       R -> W (in SPG56; dbSNP:rs141431913).
FT                                {ECO:0000269|PubMed:23176821}.
FT                                /FTId=VAR_069578.
SQ   SEQUENCE   544 AA;  61987 MW;  01A0729318605770 CRC64;
     MSSPGPSQPP AEDPPWPARL LRAPLGLLRL DPSGGALLLC GLVALLGWSW LRRRRARGIP
     PGPTPWPLVG NFGHVLLPPF LRRRSWLSSR TRAAGIDPSV IGPQVLLAHL ARVYGSIFSF
     FIGHYLVVVL SDFHSVREAL VQQAEVFSDR PRVPLISIVT KEKGVVFAHY GPVWRQQRKF
     SHSTLRHFGL GKLSLEPKII EEFKYVKAEM QKHGEDPFCP FSIISNAVSN IICSLCFGQR
     FDYTNSEFKK MLGFMSRGLE ICLNSQVLLV NICPWLYYLP FGPFKELRQI EKDITSFLKK
     IIKDHQESLD RENPQDFIDM YLLHMEEERK NNSNSSFDEE YLFYIIGDLF IAGTDTTTNS
     LLWCLLYMSL NPDVQEKVHE EIERVIGANR APSLTDKAQM PYTEATIMEV QRLTVVVPLA
     IPHMTSENTV LQGYTIPKGT LILPNLWSVH RDPAIWEKPE DFYPNRFLDD QGQLIKKETF
     IPFGIGKRVC MGEQLAKMEL FLMFVSLMQS FAFALPEDSK KPLLTGRFGL TLAPHPFNIT
     ISRR
//
